FTK Stock Analysis: Flotek Industries | NYSE
Oil & Gas Equipment & Services | NYSE, USA | Market Cap: 810m USD | 12M Return: 91.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 6.17M
Qual. Beats: 0
Rev. Trend: 78.5%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Flotek Industries, Inc. (FTK) is a Houston-based chemical and data analytics company that operates in two segments: Chemistry Technologies (CT) and Data Analytics (DA). The CT segment provides proprietary and specialty chemistries, logistics, and technology services to a broad customer base spanning integrated oil and gas companies, oilfield services firms, national and state-owned oil companies, and renewable energy players including geothermal and solar. The DA segment delivers near real-time analytical measurement, digital process-control solutions, emissions and carbon-intensity optimization tools, and equipment rental across the energy value chain, with growing applications in power and digital valuation.
As a small-cap specialty chemicals issuer listed on the NYSE, Floteks earnings are closely tied to upstream oilfield activity, which makes the business cyclical and sensitive to drilling budgets and commodity prices. Its expansion into sustainability-focused chemistries and energy-related data analytics reflects a broader industry shift among oilfield service and chemical suppliers toward lower-emission chemistries and digitalized production monitoring, aimed at reducing reliance on traditional drilling volumes for revenue growth.
- US drilling activity rebound lifts Chemistry Technologies revenue
- Data Analytics segment scales with oilfield digitalization demand
- Energy transition fuels demand for sustainable chemistry solutions
| Net Income: 29.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -3.86 > 1.0 |
| NWC/Revenue: 22.65% < 20% (prev 26.21%; Δ -3.56% < -1%) |
| CFO/TA -0.00 > 3% & CFO -568k > Net Income 29.8m |
| Net Debt (52.0m) to EBITDA (30.0m): 1.74 < 3 |
| Current Ratio: 1.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (38.3m) vs 12m ago 20.75% < -2% |
| Gross Margin: 24.72% > 18% (prev 21.29%; Δ 3.43% > 0.5%) |
| Asset Turnover: 125.3% > 50% (prev 118.7%; Δ 6.66% > 0%) |
| Interest Coverage Ratio: 5.06 > 6 (EBIT TTM 25.5m / Interest Expense TTM 5.04m) |
| A: 0.25 (Total Current Assets 125.8m - Total Current Liabilities 68.7m) / Total Assets 231.8m |
| B: -1.21 (Retained Earnings -281.1m / Total Assets 231.8m) |
| C: 0.13 (EBIT TTM 25.5m / Avg Total Assets 201.0m) |
| D: 1.04 (Book Value of Equity 118.2m / Total Liabilities 113.7m) |
| Altman-Z'' = -0.39 = B |
| DSRI: 1.12 (Receivables 103.0m/73.8m, Revenue 252.0m/202.0m) |
| GMI: 0.86 (GM 21.29% / 24.72%) |
| AQI: 0.94 (AQ_t 0.35 / AQ_t-1 0.37) |
| SGI: 1.25 (Revenue 252.0m / 202.0m) |
| TATA: 0.13 (NI 29.8m - CFO -568k) / TA 231.8m) |
| Beneish M = -2.90 (Cap -4..+1) = A |
As of July 13, 2026, the stock is trading at USD 25.56 with a total of 292,922 shares traded. Over the past week, the price has changed by +15.19%, over one month by +3.73%, over three months by +62.70% and over the past year by +91.60%.
Current recommended Stop Loss: 23.60 (which is 7.7% or 1.2 ATR below the current price).
Flotek Industries has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy FTK.
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 24.3 | -4.9% |
P/E Trailing = 28.3544
P/E Forward = 33.67
P/S = 3.2164
P/B = 6.7931
P/EG = 4.317
Revenue TTM = 252.0m USD
EBIT TTM = 25.5m USD
EBITDA TTM = 30.0m USD
Long Term Debt = 39.6m USD (from longTermDebt, last quarter)
Short Term Debt = 6.11m USD (from shortTermDebt, last quarter)
Debt = 57.8m USD (from shortLongTermDebtTotal, last quarter) + Leases 6.78m
Net Debt = 52.0m USD (calculated: Debt 57.8m - CCE 5.78m)
Enterprise Value = 862.4m USD (810.4m + Debt 57.8m - CCE 5.78m)
Interest Coverage Ratio = 5.06 (Ebit TTM 25.5m / Interest Expense TTM 5.04m)
EV/FCF = -291.8x (Enterprise Value 862.4m / FCF TTM -2.96m)
FCF Yield = -0.34% (FCF TTM -2.96m / Enterprise Value 862.4m)
FCF Margin = -1.17% (FCF TTM -2.96m / Revenue TTM 252.0m)
Net Margin = 11.83% (Net Income TTM 29.8m / Revenue TTM 252.0m)
Gross Margin = 24.72% ((Revenue TTM 252.0m - Cost of Revenue TTM 189.7m) / Revenue TTM)
Gross Margin QoQ = 21.28% (prev 22.50%)
Tobins Q-Ratio = 3.72 (Enterprise Value 862.4m / Total Assets 231.8m)
Interest Expense / Debt = 8.72% (Interest Expense 5.04m / Debt 57.8m)
Taxrate = 25.65% (1.61m / 6.27m)
NOPAT = 19.0m (EBIT 25.5m * (1 - 25.65%))
Current Ratio = 1.83 (Total Current Assets 125.8m / Total Current Liabilities 68.7m)
Debt / Equity = 0.49 (Debt 57.8m / totalStockholderEquity, last quarter 118.2m)
Debt / EBITDA = 1.74 (Net Debt 52.0m / EBITDA 30.0m)
Debt / FCF = -17.61 (negative FCF - burning cash) (Net Debt 52.0m / FCF TTM -2.96m)
Total Stockholder Equity = 103.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 14.83% (Net Income 29.8m / Total Assets 231.8m)
RoE = 28.83% (Net Income TTM 29.8m / Total Stockholder Equity 103.4m)
RoCE = 17.85% (EBIT 25.5m / Capital Employed (Equity 103.4m + L.T.Debt 39.6m))
RoIC = 11.61% (NOPAT 19.0m / Invested Capital 163.4m)
WACC = 12.98% (E(810.4m)/V(868.2m) * Re(13.44%) + D(57.8m)/V(868.2m) * Rd(8.72%) * (1-Tc(0.26)))
Discount Rate = 13.44% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 86.67 | Cagr: 10.71%
[DCF] Fair Price = unknown (Cash Flow -2.96m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.07 | # QB: 0
Revenue Correlation: 78.47 | Revenue CAGR: 10.60% | SUE: 1.41 | # QB: 2
EPS current Quarter (2026-06-30): EPS=0.12 | Chg30d=-32.35% | Revisions=-25% | Analysts=2
EPS next Quarter (2026-09-30): EPS=0.16 | Chg30d=+4.84% | Revisions=+25% | Analysts=4
EPS current Year (2026-12-31): EPS=0.54 | Chg30d=-27.03% | Revisions=-25% | GrowthEPS=-45.1% | GrowthRev=+20.2%
EPS next Year (2027-12-31): EPS=0.80 | Chg30d=-13.98% | Revisions=+25% | GrowthEPS=+48.1% | GrowthRev=+11.9%
[Analyst] Revisions Ratio: +0% (up=2, down=2)